GL1X · GenesisL1 explorer

MolNFT v1 · #102646 · protein

Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide UK601 (bicyclic 1)

4OS1: “Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide UK601…”. X-ray diffraction, 2 ligands (SO4, NH2), 2 pockets (best druggability 0.37). MolNFT v1 #102646 on GenesisL1: 3D structure…

PDB
4OS1
Type
protein
Length
259 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Urokinase-type plasminogen activator; Bicyclic peptide UK601 (bicyclic 1)
EC
3.4.21.73
UniProt
P00749
Ligands
SO4, NH2
Pockets
2 · best druggability 0.37

Structure

x-ray diffraction · 2 distinct chains · 10% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUrokinase-type plasminogen activator (EC 3.4.21.73)protein24511% helix, 39% strandP00749
BBicyclic peptide UK601 (bicyclic 1)protein140% helix, 0% strand—

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 2 copies · chains A
  • NH2 · Amino group · ion · chains B
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1740.370.7716empty
2740.310.7421empty

Interfaces

1 interface between chains.

  • A–B · 733 Ų buried · 20 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide, 1 modified (disulfide, nonstandard).

Compared structures

  • 4OS1 · Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.